IlluminOss Medical, a commercial stage medical device company, has appointed Amy Orlick Berman as the company's vice president of clinical affairs.
Ms. Berman will be responsible for the global clinical trial program at IlluminOss, including the U.S. Lightfix trial toward securing approval for the treatment of impeding and actual fractures of the humerus in patients with metastatic bone disease, according to a news release.
Prior to joining IlluminOss, Ms. Berman was at Cordis, a Johnson & Johnson company, for nearly a decade where she held roles of increasing responsibility and oversaw various high-profile clinical research programs in the U.S., Europe and Japan.
Ms. Berman holds a master's degree in public health from Columbia University.
More articles on executive moves:
Community Hospital Corporation names Jim Coleman SVP, Southeast hospital operations